Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The Niraparib-versus-niraparib–bevacizumab trial record is now displayed, including its study design, eligibility criteria, treatment arms, outcomes, and locations.
    Difference
    54%
    Check dated 2026-11-10T19:29:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T19:34:57.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the website transition and its terminology update has been added, and the site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:19:25.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-06T19:26:24.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record, replacing detailed trial information with a generic error page and a Home link.
    Difference
    19%
    Check dated 2026-09-22T22:09:03.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page’s revision indicator was updated from v3.6.6 to v3.7.0, signaling a frontend/software update. The study details and related information remain the same.
    Difference
    0.1%
    Check dated 2026-09-15T20:30:50.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.